Basic Information
Basic information for SNHG14-327-14aa-3
Peptide Name SNHG14-327-14aa-3
Genome Position chr15:25223059-25223100[+]
Species Human
Peptide Sequence MVRLEEDFHWACFS
Peptide Length 14
Unique No (SNHG14-203-14aa-1,SNHG14-207-14aa-1,SNHG14-225-14aa-3,SNHG14-228-14aa-1,SNHG14-244-14aa-4,SNHG14-273-14aa-2,SNHG14-285-14aa-1,SNHG14-294-14aa-4,SNHG14-295-14aa-1,SNHG14-317-14aa-3,SNHG14-326-14aa-3,SNHG14-329-14aa-4,SNHG14-331-14aa-1)
Grand Average of Hydropathicity -0.0071
Relative Molecular Mass 2004.19
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000669911;SNHG14-327
Transcript Length 4147
Coding Ability 0.4847
DNA Sequence Corresponding to Peptide ATGGTGAGACTTGAGGAAGACTTCCACTGGGCCTGCTTTTCC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :